Cargando…
Protection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirus
BACKGROUND: The generation of anti-adenovirus neutralizing antibody (NAb) in humans severely restricts the utilization of recombinant adenovirus serotype 5 (Ad5) vectors in gene therapy for a wide range of clinical trials. To overcome this limitation, we ionically complexed Ad5 with a newly synthesi...
Autores principales: | Zeng, Qin, Han, Jianfeng, Zhao, Dong, Gong, Tao, Zhang, Zhirong, Sun, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299205/ https://www.ncbi.nlm.nih.gov/pubmed/22412299 http://dx.doi.org/10.2147/IJN.S27526 |
Ejemplares similares
-
The infectivity of progeny adenovirus in the presence of neutralizing antibody
por: Hirai, Takamasa, et al.
Publicado: (2021) -
Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
por: Zhao, Hua, et al.
Publicado: (2018) -
Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China
por: Wang, Xiang, et al.
Publicado: (2014) -
Seroprevalence of human adenovirus type 5 neutralizing antibodies in the Philippines
por: Francisco, Abialbon G., et al.
Publicado: (2023) -
Redirecting adenovirus to pulmonary endothelium by cationic liposomes
por: Ma, Z, et al.
Publicado: (2002)